Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™
Osheru Inc. · NCT07144761
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 35+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 200
- US sites recruiting
- 5
- Study start
- August 2025
- Record last updated
- August 27, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The objective of this study is to evaluate patient-reported outcomes, surgeon reported outcomes, bruising, symmetry, the success of tissue adhesive for wound closure, and case time.
Being studied: Ziplyft
Conditions: Blepharoplasty
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Provide signed written consent prior to participation in any study-related procedures.
- Ability, comprehension, and willingness to follow study instructions, and likely to complete all study visits.
- Male or female adults, ≥ 35 years old at the Preoperative Visit
- Willing to return for required follow-up visits.
- Subjects with excess eyelid skin are eligible to undergo the procedure in the opinion of the investigator.
- Female subjects must be 1-year postmenopausal, surgically sterilized, or, if of childbearing potential, have a negative urine pregnancy test at the Preoperative Visit. Women of childbearing potential must use an acceptable form of contraception throughout the study. Acceptable methods include at least one of the following: intrauterine (intrauterine device), hormonal (oral, injection, patch, implant, ring), barrier with spermicide (condom, diaphragm), or abstinence.
Exclusion Criteria
- Subjects with a current Ptosis diagnosis
- Subjects with a history of Graves' Disease
- Subjects with Myasthenia Gravis
- Subjects that in the opinion of the investigator are anatomically not conducive to using devices (e.g., heavy brow, severe hollowing of the upper eyelid, history of ocular or orbital trauma).
- Subjects that have had any previous surgery eyelid or eyebrow region.
- Use of anticoagulation therapy, including, but not limited to Aspirin, NSAIDS, Ibuprofen within 7 days and Xarelto, Warfarin, Enoxaparin, Plavix within 3 days prior to planned study procedure.
- Active or recent (within 3 months) tobacco user
- Allergy to adhesive glue
- Participation in any study of an investigational, interventional product within 30 days prior to the Preoperative Visit or at any time during the study period.
- Pregnant or nursing females.
Recruiting US locations
Center for Excellence in Eye Care
Miami, FL 33176
Site contact: Elizabeth Vargas · 305-598-2020 · study2@centerforeyecare.com
Vance Thompson Vision
Alexandria, MN 56308
Site contact: Tiffany Facile, MBA · 605-254-7126 · tiffany.facile@vancethompsonvision.com
Eye Care Specialists
Kingston, PA 18704
Site contact: Patti Meyers · 570-714-5910 · patti.myers@vipeyes.com
Vance Thompson Vision
Sioux Falls, SD 57108
Site contact: Tiffany Facile, MBA · 605-254-7126 · tiffany.facile@vancethompsonvision.com
The Eye Centers of Racine and Kenosha, LTD
Kenosha, WI 53142
Site contact: Pam Lightfield · 262-898-5677 · plightfield@amazingeye.com
Study contacts (from the official record)
- Patricia Buehler, MD · 541-419-4412 · pbuehler@osheru.com
- Becky Weathers · 541-312-4622 · bweathers@osheru.com